This study intends to compare the combination of general anesthesia (GA) and single-shot bilateral thoracic paravertebral block (TPVB) by ropivacaine in the patients undergoing off-pump coronary artery bypass surgery ( OPCAB) with traditional general anesthesia (GA) perioperative management of patients, committed to reducing patient's physical and psychological stress by surgical trauma, achieve the purpose of fast recovery, in order to establish an more effective perioperative management during off-pump coronary artery bypass surgery, improve patients' satisfaction and to accelerate postoperative rehabilitation safely.
This study intends to compare the combination of general anesthesia (GA) and single-shot bilateral thoracic paravertebral block (TPVB) by ropivacaine in the patients undergoing off-pump coronary artery bypass surgery ( OPCAB) with traditional general anesthesia (GA) perioperative management of patients, committed to reducing patient's physical and psychological stress by surgical trauma, achieve the purpose of fast recovery, in order to establish an more effective perioperative management during off-pump coronary artery bypass surgery, improve patients' satisfaction and to accelerate postoperative rehabilitation safely. Patients included in the study (approximately 60 cases) will be randomly divided into PVB(T2/3+T5/6)+GA experimental group (A), PVB(T3/4)+GA experimental group (B)the conventional GA control group (C). All groups received the preoperative preparation, anesthesia and postoperative treatment according to the traditional manner, the group A of patients has been received bilateral thoracic paravertebral block (TPVB T2/3+T5/6) by ropivacaine(0.3%,10ml\*4), group B will received bilateral thoracic paravertebral block (TPVB T3/4)by ropivacaine(0.3%,20ml\*2).,while the group C will received the conventional general anesthesia management without block.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
60
group A under TPVB((TPVB T2/3+T5/6) by ropivacaine(0.3%,10ml\*4)program
1. Apply Transesophageal Echocardiography(TEE)after anesthesia induction and draw 400ml autologous blood (Haemonetics®)used for the postoperative transfusion; 2. Goal-directed fluid management
Protective ventilation strategy(Low tidal volume about 6\~7ml/kg, joint use of PEEP)
1. Bilateral thoracic paravertebral block before induction of anesthesia; 2. Fast channel anesthesia • Induction use Sufentanil 0.5\~1ug/kg, Vecuronium for Injection 0.15mg/kg and Etomidate 0.2\~0.6mg/kg; ②. Maintain use Sufentanil Hydrochloride for Injection 0.01\~0.04ug/kg•min, Sevoflurane 0.5\~1.5MAC(minimum alveolar concentration) and Infusing Dexmedetomidine which load dose 0.5μg/kg in 10min then changed into 0.5-1.0μg/kg•h,Vecuronium 0.06\~0.12mg/kg•h; ③. Intravenous hydromorphone Hydrochloride Injection 0.15mg/kg before surgery over.
group B under(TPVB T3/4)by ropivacaine(0.3%,20ml\*2)program
Xiangya Hospital of Central South University
Changsha, Hunan, China
Fasting blood glucose
1day before and 4days after operation
Time frame: baseline and 4 days
Blood Lactic Acid
1day before and 4days after operation
Time frame: baseline and 4 days
Creatine kinase isoenzymes
1day before and 4days after operation
Time frame: baseline and 4 days
Myoglobin
1day before and 4days after operation
Time frame: baseline and 4 days
Troponin I
1day before and 4days after operation
Time frame: baseline and 4 days
White Blood Cell
1day before and 4days after operation
Time frame: baseline and 4 days
C-reactive protein
1day before and 4days after operation
Time frame: baseline and 4 days
N-terminal B-type natriuretic peptide(NT-proBNP)
1day before and 4days after operation
Time frame: baseline and 4 days
Perioperative major adverse events
Time frame: From pre-surgery to discharge, up to 4 weeks
Perioperative use of vasoactive drug species
Time frame: From pre-surgery to discharge, up to 4 weeks
Vasoactive drugs Support Hours
Time frame: From the start of drugs to stop them, up to 4 weeks
Time after deactivation of vasoactive drugs
Time frame: From the end of surgery to the deactivation of vasoactive drugs, up to 4 weeks
Postoperative tracheal tube time
Time frame: From the end of surgery to the removal of tracheal tube, up to 4 weeks
Duration of mechanical ventilation after surgery
Time frame: From the end of surgery to the recovery of spontaneous breathing, up to 4 weeks
The time after the ICU until discharge
Time frame: From leaving the ICU to discharge from hospital, up to 4 weeks
Length of ICU stay
Time frame: From ICU admission to discharge from ICU, up to 4 weeks
Recovery time
Time frame: From the end of surgery to recover, up to 4 weeks
Time to first bowel movement
Time frame: From the end of surgery to first bowel movement, up to 2 weeks
Postoperative to normal eating time
Time frame: From the end of surgery to normal eating, up to 2 weeks
The total length of hospital stay
Time frame: From admission to discharge, up to 5 weeks
Visual analog pain score
Time frame: From the end of surgery, up to 48 hours
Ramsay score
Time frame: From the end of surgery, up to 48 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.